Adversarial debiasing for age-equitable diabetes prediction: performance–fairness trade-offs and partition dependency in machine learning - Report - MDSpire

Adversarial debiasing for age-equitable diabetes prediction: performance–fairness trade-offs and partition dependency in machine learning

  • By

  • Vinod Kumar Yata

  • Sravanthi Jena

  • Meera Indracanti

  • Shivaprasad Chitta

  • Narasaiah Kolliputi

  • July 17, 2026

Share

Clinical Report: Mitigating Age Bias in Diabetes Risk Prediction through Adversarial Debiasing

Overview

This study evaluates the effectiveness of adversarial debiasing with a gradient reversal layer (GRL) in improving diabetes risk prediction while addressing age-related biases. The findings indicate that the adversarial model enhances recall for older age groups, but its impact on fairness across different demographic partitions is variable.

Background

Diabetes mellitus is a significant global health issue, affecting over 500 million adults and leading to serious complications. Machine learning models have shown promise in diabetes risk prediction but may harbor biases that affect diagnostic accuracy across demographic groups, particularly age. Addressing these biases is crucial to ensure equitable healthcare delivery.

Data Highlights

ModelRecall (>50 years)ROC-AUCRecall Parity Gap
Adversarial Model0.77780.78960.2153
Logistic Regression0.55560.78520.0996

Key Findings

  • The adversarial model improved recall for the >50 years age group by 22.22 percentage points.
  • Overall discrimination (ROC-AUC) was slightly improved from 0.7852 to 0.7896.
  • The recall parity gap increased from 0.0996 to 0.2153 for the adversarial model.
  • Across five random seeds, the mean recall parity gap showed variability, with three out of five seeds showing a reduction in the fairness gap.

Clinical Implications

Clinicians should be aware of potential biases in machine learning models.

Conclusion

Adversarial debiasing can improve diabetes risk prediction for underrepresented age groups, but its effectiveness in ensuring fairness is variable.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. aace endocrine ai, AI model identifies CKD risk in older adults, 2026
  3. conexiant, Retinal Age Model Tied to Disease Risk, 2026
  4. Intensive Care Medicine, The Limitations of Federated Learning in Addressing Ingrained Biases in Clinical Medicine, 2024
  5. American Diabetes Association, Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026, Diabetes Care
  6. New England Journal of Medicine, Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin, 2002
  7. PubMed, Geographic disparities and methodological quality of type 2 diabetes prediction models: a systematic review and meta-analysis of 97 models, 2023
  8. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026 | Diabetes Care | American Diabetes Association
  9. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | New England Journal of Medicine
  10. Geographic disparities and methodological quality of type 2 diabetes prediction models: a systematic review and meta-analysis of 97 models - PubMed

Original Source(s)

Related Content